Compounding Pharmacies Market Size

Compounding Pharmacies Market size was valued at USD 13.13 billion in 2024 and is likely to exceed USD 41.14 billion by the end of 2037, expanding at over 9.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of compounding pharmacies is evaluated at USD 14.1 billion.

The growth of the market can be attributed to growing prevalence of chronic disease. Almost 59% of American adults in 2022 had at least one chronic illness. Moreover, dysphagia could be brought on by some chronic conditions, including Parkinson's disease, muscular dystrophy, and multiple sclerosis which could cause harm to the brain. The capacity to swallow may be impacted by sudden neurological damage, such as that caused by a stroke, brain injury, or spinal cord injury. Hence, the demand for compounding pharmacies is estimated to boost, which in turn is expected to boost the growth of the market. Moreover, pharmacy chains that specialize in compounding make it easier for patients to take their prescription medications. Given that they assemble the prescriptions for customers, they are able to create easier-to-take treatments including liquid suspension and chewable tablets.

Moreover, there has been a growing drug shortage and rise in drug failure all around the globe. Medication scarcity is a global problem that impacts high-, middle-, and low-income nations. Since, the problem is escalating and affecting the entire globe, many nations have produced a variety of solutions which also includes focusing more on compounding. All sorts of medications are susceptible to the shortage, including vital life-saving medications, cancer treatments, antimicrobial drugs, analgesics, opioids, cardiovascular medications, radiopharmaceuticals, and parenteral goods. However, the major factor contributing to the shortage of drugs is a regulatory issue. The approval of pharmacy drugs is one of the most time-consuming processes, and  in the case of compounding medication, it doesn’t require any approval from the FDA and could be commercially distributed. Hence, the demand for compounding pharmacies is estimated to increase.